GLP1R and type 2 diabetes mellitus: Glucagon-like peptide-1 (GLP-1) receptor agonists have also been implicated as a potential pharmacological therapeutic treatment for T2DM-induced autonomic dysfunction, though its efficacy has recently been debated.